A weakened diaphragm could be related to the persistent shortness of breath some people experience long after COVID-19 hospitalization, a small study suggested. Whether patients had received ...

Dyspnea is one of the most common symptoms reported by patients receiving palliative care. It is not only a symptom of severe or chronic pulmonary disease, but is also associated with a wide variety ...

Despite a higher incidence of dyspnea among patients with acute coronary syndromes (ACS) on ticagrelor compared with clopidogrel, the side effect is usually not serious and resolves spontaneously or ...

Am J Health Syst Pharm. 2005;62(3):319-320. The Clinical Consultation column provides brief recommendations on handling specific pharmacothera-peutic problems in clinical practice. The problems ...

Dyspnea, a sensation of breathlessness, during light daily activities can be used as an indicator of exercise intolerance and low fitness. According to a study on Finnish twins, persistent or ...

Please provide your email address to receive an email when new articles are posted on . Recently, our palliative care service at Roswell Park Cancer Institute was called to see a patient for ...

Figure 1. Hyperinflation of the lungs points to a pulmonary cause of dyspnea. There are guidelines for the management of each as a separate condition, but how do you evaluate and treat them when they ...

Shortness of breath can be because of multiple reasons. In the current scenario, if a person is suffering from shortness of breath, it is assumed to be a symptom of COVID. However, many other diseases ...

Pune, July 25, 2024 (GLOBE NEWSWIRE) -- Dyspnea Treatment Market Growth Analysis: “According to SNS Insider Research, The Dyspnea Treatment Market Size was valued at US$ 6.16 billion in 2023, and is ...

The natriuretic peptides, specifically brain natriuretic peptide (BNP), are the most specific and applicable laboratory tests available to establish fluid overload associated with HF. 9 BNP is ...